INBS
INTELLIGENT BIO SOLUTIONS INC.
Next earnings ≈ Aug 12, 2026 · est. from filing cadence
Last earnings +3.0% on 2026-05-14
$2.25
▲ +4.65%$2.25▼ -87.70%
over 1Y
L $2.15EODHDH $22.50
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+4.7%
1W-5.5%
1M-9.6%
3M-30.1%
YTD-71.5%
1Y-87.7%
Avoid
Conviction
Horizon
Medium (3–12mo)
Street · 7 analysts
Buy
Revenue declined -1.9% YoY.
Revenue (FY2025) $3.05M · FY2025
INTELLIGENT BIO SOLUTIONS INC. shows $3.05M in FY2025 revenue (-1.9% YoY), a -346.2% net margin, and -352.7% ROE.
Financials · annual, by fiscal year
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $1.98M | $437K | $1.26M | $3.11M | $3.05M |
| Gross profit | — | — | $327K | $1.43M | $1.25M |
| Operating income | -$5.57M | -$8.34M | -$12.6M | -$10.3M | -$10.6M |
| Net income | -$7.04M | -$8.31M | -$10.6M | -$10.2M | -$10.6M |
| Diluted EPS | — | -$11.33 | -$127.00 | -$6.38 | -$2.00 |
| Net margin | -355.3% | -1900.1% | -845.9% | -326.4% | -346.2% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Key statistics
Valuation
Enterprise value$20.8M
EV / EBITDA—
EV / Sales6.8
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield-52.3%
FCF yield-49.0%
Quality & risk
ROIC (est.)-181.0%
Free cash flow-$9.91M
Total debt$1.65M
Net cash-$630K
Altman Z-Score-12.45 distress
Piotroski F-Score2/8
Capital returns
Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY+111.3%
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Disclosure timeline
SEC · 8-Ks + reportsSome governance/structural items recently, but no outright red flags.
- 8-K Reg FD disclosure2026-06-16
- 8-K Reg FD disclosure2026-06-02
- 8-K Earnings results2026-05-14
- 10-Q Quarterly report2026-05-13
- 8-K Reg FD disclosure2026-04-20
- 8-K Officer / director change2026-03-23
- 8-K Reg FD disclosure2026-02-25
- 10-Q Quarterly report2026-02-12
- S-3 Shelf registration (potential raise)2026-01-09
Recent filings
all on EDGAR ↗8-KPeriod ending 2026-06-162026-06-16open ↗8-KPeriod ending 2026-06-022026-06-02open ↗SCHEDULE 13GFiling2026-05-15open ↗8-KPeriod ending 2026-05-132026-05-14open ↗10-QPeriod ending 2026-03-312026-05-13open ↗8-KPeriod ending 2026-04-202026-04-20open ↗8-KPeriod ending 2026-03-182026-03-23open ↗424B5Filing2026-03-23open ↗4Period ending 2026-03-182026-03-20open ↗4Period ending 2026-03-182026-03-20open ↗4Period ending 2026-03-182026-03-20open ↗4Period ending 2026-03-182026-03-20open ↗
Frequently asked
- Is INTELLIGENT BIO SOLUTIONS INC. (INBS) a buy?
- INBS currently carries a Avoid rating with 4/5 conviction, derived from its latest SEC filings. Revenue declined -1.9% YoY.
- What is INTELLIGENT BIO SOLUTIONS INC.'s quality score?
- INBS scores 40.33333333333333/100 (grade D) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.
Sources: SEC EDGAR (CIK 0001725430, latest 10-Q filed 2026-05-13) · EODHD · as of 6/25/2026, 11:28:45 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.